Stockscreener 앱 받기
24.58
0.16%
0.04
시간 외 거래:
24.58
전일 마감가:
$24.54
열려 있는:
$24.59
하루 거래량:
235.48K
Relative Volume:
0.25
시가총액:
$1.90B
수익:
$1.53B
순이익/손실:
$40.23M
주가수익비율:
20.31
EPS:
1.21
순현금흐름:
$60.93M
1주 성능:
+4.24%
1개월 성능:
+26.05%
6개월 성능:
-16.96%
1년 성능:
-37.22%
1일 변동 폭
$24.39
$24.87
1주일 범위
$23.44
$24.87
52주 변동 폭
$16.80
$45.42
Integra Lifesciences Holdings Corp Stock (IART) Company Profile
명칭
Integra Lifesciences Holdings Corp
전화
(609) 275-0500
주소
1100 CAMPUS ROAD, PRINCETON, NJ
IART을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
IART
Integra Lifesciences Holdings Corp
|
24.58 | 1.90B | 1.53B | 40.23M | 60.93M | 0.50 |
|
ABT
Abbott Laboratories
|
118.77 | 206.00B | 41.22B | 5.77B | 6.49B | 3.29 |
|
SYK
Stryker Corp
|
392.15 | 149.49B | 21.97B | 3.59B | 3.21B | 9.33 |
|
BSX
Boston Scientific Corp
|
90.66 | 133.62B | 15.91B | 1.79B | 1.89B | 1.21 |
|
MDT
Medtronic Plc
|
86.54 | 110.97B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
71.35 | 42.08B | 6.60B | 4.16B | 490.10M | 6.93 |
Integra Lifesciences Holdings Corp Stock (IART) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-10-07 | 업그레이드 | BTIG Research | Sell → Neutral |
| 2024-07-30 | 다운그레이드 | BTIG Research | Neutral → Sell |
| 2024-07-30 | 다운그레이드 | Citigroup | Neutral → Sell |
| 2024-05-07 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2024-05-07 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2024-04-03 | 업그레이드 | Citigroup | Sell → Neutral |
| 2023-12-05 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2023-11-14 | 개시 | CL King | Buy |
| 2023-08-24 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2023-07-12 | 업그레이드 | Jefferies | Hold → Buy |
| 2023-06-08 | 다운그레이드 | Argus | Buy → Hold |
| 2023-05-24 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2023-05-23 | 다운그레이드 | Citigroup | Neutral → Sell |
| 2022-10-12 | 개시 | Jefferies | Hold |
| 2022-07-25 | 개시 | Morgan Stanley | Equal-Weight |
| 2022-04-13 | 다운그레이드 | Truist | Buy → Hold |
| 2021-12-17 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2021-09-15 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2020-10-08 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2020-05-27 | 개시 | Citigroup | Neutral |
| 2020-04-03 | 개시 | SunTrust | Buy |
| 2020-01-07 | 다운그레이드 | Piper Jaffray | Overweight → Neutral |
| 2020-01-07 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2019-01-03 | 개시 | SunTrust | Buy |
| 2018-11-28 | 개시 | UBS | Neutral |
| 2018-08-07 | 다운그레이드 | BofA/Merrill | Neutral → Underperform |
| 2018-07-26 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2018-07-02 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2018-01-05 | 재개 | Cantor Fitzgerald | Neutral |
| 2018-01-02 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2017-11-09 | 재확인 | RBC Capital Mkts | Sector Perform |
| 2017-10-30 | 다운그레이드 | Wells Fargo | Outperform → Market Perform |
| 2017-10-27 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2017-06-30 | 개시 | Cantor Fitzgerald | Overweight |
| 2017-05-02 | 재확인 | RBC Capital Mkts | Sector Perform |
| 2017-01-13 | 재확인 | RBC Capital Mkts | Sector Perform |
| 2017-01-06 | 업그레이드 | JMP Securities | Mkt Perform → Mkt Outperform |
| 2016-12-12 | 개시 | UBS | Buy |
모두보기
Integra Lifesciences Holdings Corp 주식(IART)의 최신 뉴스
Integra LifeSciences Holdings Co. (NASDAQ:IART) Shares Sold by Victory Capital Management Inc. - Defense World
Chronic Wound Care Market to Expand at a Modest 4.17% CAGR through 2031 | SkyQuest Technology - Benzinga
Regenerative Medicine Market to grow by USD 70.11 Billion (2024-2028), rising prevalence of chronic diseases to drive revenue, Report with AI-powered insightsTechnavio - The Malaysian Reserve
Integra Lifesciences (IART) Stock Dips Amid Financial Concerns - GuruFocus.com
Integra’s DuraSeal® Dural Sealant Saves Healthcare Costs According to an Economic Evaluation Published in the Journal of Comparative Effectiveness Research - Yahoo Finance
Fuller & Thaler Asset Management, Inc. Expands Stake in Integra Lifesciences Holdings Corp - GuruFocus.com
Capital Research Global Investors Reduces Stake in Integra Lifes - GuruFocus.com
Integra LifeSciences Holdings Co. (NASDAQ:IART) Given Consensus Rating of "Reduce" by Analysts - MarketBeat
Integra LifeSciences : Serving Those Who Served - Marketscreener.com
Easterly Investment Partners LLC Has $1.12 Million Stock Holdings in Integra LifeSciences Holdings Co. (NASDAQ:IART) - MarketBeat
Leeward Investments LLC MA Has $6.83 Million Stock Holdings in Integra LifeSciences Holdings Co. (NASDAQ:IART) - MarketBeat
Integra Lifesciences (IART) Stock Sees Sharp 5.09% Decline Amid Market Fluctuations - GuruFocus.com
Olstein Capital Management L.P. Has $2.82 Million Stake in Integra LifeSciences Holdings Co. (NASDAQ:IART) - MarketBeat
Wound Dressing Market: Size, Share, Trends, and Global Analysis - openPR
Integra LifeSciences price target raised to $22 from $16 at Citi - Yahoo Finance
Louisiana State Employees Retirement System Sells 2,200 Shares of Integra LifeSciences Holdings Co. (NASDAQ:IART) - Defense World
IART (Integra Lifesciences Holdings) PE Ratio without NRI : 8.77 (As of Nov. 05, 2024) - GuruFocus.com
Integra Q3 Earnings, Revenues Beat, Stock Up Despite Margin Pressure - MSN
Integra LifeSciences Holdings Corporation (NASDAQ:IART) Q3 2024 Earnings Call Transcript - Insider Monkey
Integra LifeSciences Holdings Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
Integra Lifesciences Holdings Corp (IART) Q3 2024 Earnings Call - GuruFocus.com
Earnings call: Integra LifeSciences reports Q3 revenue decline, new CEO By Investing.com - Investing.com South Africa
Earnings call: Integra LifeSciences reports Q3 revenue decline, new CEO - Investing.com
Integra Lifesciences Holdings Corp (IART) Q3 2024 Earnings Call Highlights: Navigating ... - Yahoo Finance
Integra Lifesciences names Mojdeh Poul as CEO - Yahoo Finance
Citi raises Integra LifeSciences target to $22, maintains sell rating - Investing.com
Why Is Integra LifeSciences Stock Soaring On Monday? - Yahoo Finance
Integra LifeSciences (NASDAQ:IART) Shares Gap UpHere's What Happened - MarketBeat
Integra Lifesciences Holdings Corp (IART) Shares Up 25.16% on No - GuruFocus.com
Q3 2024 Integra Lifesciences Holdings Corp Earnings Call Transcript - GuruFocus.com
Integra LifeSciences (IART) Beats Q3 Earnings and Revenue Estimates - Yahoo Canada Finance
Integra: Q3 Earnings Snapshot - San Antonio Express-News
Integra Lifesciences Q3 Earnings: Revenue Beats at $380.8M, GAAP EPS Misses at $(0.14) - GuruFocus.com
Is Integra LifeSciences Holdings Corporation (NASDAQ:IART) Potentially Undervalued? - Yahoo Finance
Integra LifeSciences Reports Third Quarter 2024 Financial Results - Yahoo Finance
Integra LifeSciences Announces Appointment of Mojdeh Poul as President and Chief Executive Officer - Yahoo Finance
Integra LifeSciences Holdings Co. (NASDAQ:IART) Shares Acquired by State of Alaska Department of Revenue - MarketBeat
Integra Lifesciences Holdings Corp (IART) Q3 2024 Earnings Repor - GuruFocus.com
Integra Lifesciences Holdings Corp (IART) Q3 2024 Earnings Report Preview: What To Look For - Yahoo Finance
Check Out Integra Lifesciences Holdings Corp (IART)’s Trade Data Rather Than the Analysts’ Views - SETE News
Integra LifeSciences to Host Third Quarter 2024 Financial Results Conference Call on November 4, 2024 - Yahoo Finance
Integra Lifesciences Holdings Corp [IART] Investment Appeal on the Rise - Knox Daily
The Manufacturers Life Insurance Company Decreases Position in Integra LifeSciences Holdings Co. (NASDAQ:IART) - MarketBeat
Investor’s Delight: Integra Lifesciences Holdings Corp (IART) Closes Strong at 19.27, Up 6.46 - The Dwinnex
Integra Lifesciences Holdings Corp [IART] Records 200-Day SMA of $30.67 - Knox Daily
Integra Lifesciences Holdings Corp (IART) deserves deeper analysis - US Post News
Ultrasonic Aspirator Market Expected to Grow by USD 182.9 Million from 2024-2028, Driven by AI and Rising Neurological Disorder Cases - The Malaysian Reserve
Bank of America Cuts Integra LifeSciences (NASDAQ:IART) Price Target to $18.00 - MarketBeat
The Attractiveness of Investing In Integra Lifesciences Holdings Corp (IART) is Growing - Knox Daily
A look into Integra Lifesciences Holdings Corp (IART)’s deeper side - SETE News
Integra LifeSciences (NASDAQ:IART) Stock Rating Upgraded by BTIG Research - MarketBeat
Integra Lifesciences Holdings Corp (IART) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.73%
0.14%
자본화:
|
볼륨(24시간):